Emerald Health Investor Dashboard

Company Overview:

Emerald Health Therapeutics, Inc. is a Canadian licensed producer of cannabis. Its 50%-owned Pure Sunfarms joint venture in BC is completing the conversion of its 1.1 million square foot (25 acre) greenhouse for cannabis cultivation in the Lower Mainland and its Verdélite operation in Québec is completing the build out of its 88,000 square feet indoor cultivation facility. Commercial production is expanding in both facilities. Emerald secured over 500 acres of hemp harvest in 2018 and has contracted for approximately 1000 acres in 2019 to 2022, with the objective of extracting low-cost cannabidiol (CBD). Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing proprietary, value-added cannabis products for medical and adult-use customers. Emerald is part of the Emerald Health group, which represents a broad array of companies focused on developing pharmaceutical, botanical, and nutraceutical products developed to provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

[stock_market_chart symbol=”EMH.V” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]

Key Share Information:

Key Balance Sheet Information (in Millions $CAD):

	CYQ4'16	CYQ1'17	CYQ2'17	CYQ3'17	CYQ4'17	CYQ1'18	CYQ2'18	CYQ3'18	CYQ4'18	CYQ1'19
Cash	$3.22	$14.75	$36.16	$22.82	$44.52	$89.50	$72.68	$52.91	$36.04	$15.66
Biological Assets	$0.16	$0.21	$0.19	$0.18	$0.11	$0.40	$1.37	$1.79	$1.09	$1.09
Inventory	$0.16	$0.42	$0.48	$0.80	$0.73	$0.50	$1.58	$2.84	$6.77	$9.99
Total Assets	$4.18	$16.14	$58.62	$21.95	$73.73	$123.13	$204.33	$202.64	$206.96	$240.03
Net Tangible Assets	$4.13	$16.11	$58.58	$21.92	$70.71	$120.28	$116.16	$115.44	$120.18	$148.62
Intangibles/Goodwill	$0.05	$0.04	$0.03	$0.02	$3.02	$2.85	$88.17	$87.20	$86.78	$91.41
Total Liabilities	$0.47	$0.88	$19.27	$8.60	$5.94	$3.40	$26.35	$30.73	$36.46	$65.92

Key Operating Items (Quarterly in Millions $CAD):

	CYQ4'16	CYQ1'17	CYQ2'17	CYQ3'17	CYQ4'17	CYQ1'18	CYQ2'18	CYQ3'18	CYQ4'18	CYQ1'19
Revenue	$0.25	$0.20	$0.25	$0.21	$0.94	$0.37	$0.28	$0.32	$2.11	$2.61
Change in Fair Value of Biologial Assets	-$0.20	-$0.09	-$0.05	-$0.06	-$0.16	-$0.39	-$0.98	-1.30	-2.82	-$0.72
Gross Margin	-$0.35	-$0.04	-$0.05		-$0.29	$0.29	$0.47	0.41	-3.10	-$1.65
Marketing and Sales	$0.27	$0.09	$0.11	$0.08	$0.43	$0.29	$0.87	2.69	11.33	$0.92
Investor Relations					$1.03				2.38	$0.58
Total Operating Expenses	$2.59	$1.17	$1.68	$1.72	$8.81	$5.20	$7.31	10.90	34.25	$8.26
Operating Cash Flow (Quarterly)	-$2.05		-$1.60	-$2.24	-$3.06		-$6.05	-7.44	-12.24	$20.22
Investing Cash Flow (Quarterly)	-$0.24		-$2.44	-$11.06	-$5.33		-$27.49	-12.46	-15.79	$53.00
Financing Cash Flow (Quarterly)	$5.43		$25.44	-$0.05	$30.09		$16.71	0.13	11.16	-$85.12

Listing Statement